Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Controlled Whole-body Vibration Training Reduces Risk Of Falls In People With Multiple Sclerosis: 1476 Board #129 June 2, 9: 00 AM - 10: 30 AM.
Molecular diagnostics of neurodegenerative disorders.
Pharmacological characterization of a potent inhibitor of autotaxin in animal models of inflammatory bowel disease and multiple sclerosis.
Deimination of the myelin basic protein decelerates its proteasome-mediated metabolism.
Venous hypertensive myelopathy associated with cervical spondylosis.
Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis.
Uveitis and the Diagnosis of Multiple Sclerosis.
The immunomodulator decoy receptor 3 improves locomotor functional recovery after spinal cord injury.
g-Ratio weighted imaging of the human spinal cord in vivo.
H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes.
Motoneuron Death after Human Spinal Cord Injury.
Down-regulation of neuronal L1 cell adhesion molecule expression alleviates inflammatory neuronal injury.
Pancolitis a novel early complication of Alemtuzumab for MS treatment.
Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.
MRI shows thickening and altered diffusion in the median and ulnar nerves in multifocal motor neuropathy.
Safety of secukinumab in the treatment of psoriasis.
A more in-depth interpretation of MMPI-2 in MS patients by using Harris and Lingoes subscales.
Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis.
Redox-based therapeutics in neurodegenerative disease.
Morphology of Donor and Recipient Nerves Utilised in Nerve Transfers to Restore Upper Limb Function in Cervical Spinal Cord Injury.
Improved treatment satisfaction after switching therapy to rituximab in relapsing-remitting MS.
INNOVATIVE THERAPIES REDEFINE TREATMENT GOALS IN MULTIPLE SCLEROSIS.
Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices.
Methylprednisolone microsphere sustained-release membrane inhibits scar formation at the site of peripheral nerve lesion.
Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab.
Pages
« first
‹ previous
…
744
745
746
747
748
749
750
751
752
…
next ›
last »